Royal Bank of Canada downgraded Caribou Biosciences stock, and Leerink partners updated its ratings on October 9, 2026.
2 reports, 2 independent
Updated Oct 10
Gone quiet
Reached 2 outlets in its first 24 hours
- Reports
- 2
- Developments
- 2
- Repetition
- 0%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Royal Bank of Canada downgraded Caribou Biosciences stock, and Leerink partners updated its ratings on October 9, 2026.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Leerink partners downgraded Caribou Biosciences stock from outperform to market perform.1 source
RBC downgraded Caribou Biosciences stock and Leerink updated ratings.1 source
Keep exploring
The entities involved
-
Caribou Biosciences
company in Berkeley, United States
Nothing else this week.
-
Royal Bank of Canada
financial institution in Canada
-
Leerink partners
U.S. investment bank